Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens. | Iran J Med Sci;46(4): 235-236, 2021 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens.

Negahdaripour, Manica.

Negahdaripour M; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Iran J Med Sci ; 46(4): 235-236, 2021 07.

Article in English | MEDLINE | ID: covidwho-1323535

Subject(s)

COVID-19/complications; Hyperglycemia/therapy; Adenosine Monophosphate/adverse effects; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Blood Glucose; Humans; Hyperglycemia/virology; COVID-19 Drug Treatment

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hyperglycemia Topics: Long Covid Limits: Humans Language: English Journal: Iran J Med Sci Year: 2021 Document Type: Article Affiliation country: Ijms.2021.47666

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hyperglycemia Topics: Long Covid Limits: Humans Language: English Journal: Iran J Med Sci Year: 2021 Document Type: Article Affiliation country: Ijms.2021.47666